Hosted by the HTAi Ethics Interest Group, this webinar will discuss the challenges and opportunities for being involved in conducting ethical analyses at HTA agencies. Bart Bloemen, co-chair of the IG on ethics, will present the work that the interest group is currently conducting on a paper that address this topic. Following this introduction, two speakers will present their experiences with working as an ethicist at HTA institutes. Renata Axler leads the development of ethics methodologies and practices at the Canadian Agency for Drugs and Technologies in Health (CADTH). Lars Sandman is professor at Linköping University, and also assigned as ethics advisor for Swedish health care authorities and director at the National Centre for Priorities in Health. Both will present examples of their work, and reflect upon the lessons they have learned with respect to being involved in ethical analyses in this context. These presentations will be the basis and an invitation to the audience for exchanging ideas about how to advance this interesting area of HTA.
January 17, 2024
16:00-17:00 CET (UTC+1) | 08:00 – 9:00 MST (UTC-7)
Bart Bloemen, PhD candidate and associate lecturer | Radboud University Medical Centre
Bart Bloemen holds a BASc in bio-informatics, BA in philosophy and MSc degree in molecular life sciences. Currently, he is a PhD candidate and associate Principal Lecturer in Health Technology Assessment (HTA) at Radboud University Medical Centre, Nijmegen, the Netherlands. His research activities focus on the ethics of HTA: normative decisions involved in the conduct of a technology assessment, the interplay between facts and values in assessments, and the role of evaluative frameworks such as utilitarianism and the capability approach. He was also a member of the VALIDATE consortium, an EU Erasmus+ project that developed an approach for integrating values in HTA. Bart has been actively participating in the Ethics Interest Group activities for the past few years, including supporting the workshop at the HTAi annual meeting and collaborating on a paper about competencies for ethics experts in HTA.
Renata Axler, Ethics Lead | CADTH
Dr. Renata Axler is the Ethics Lead at CADTH, Canada’s Drug and Health Technology Agency, where she works to advance methodologies and practices related to ethics in HTA and across CADTH’s work. Renata is also an Adjunct Lecturer at the Institute for Health Policy, Management and Evaluation at the University of Toronto, where she completed her PhD in Health Policy and Bioethics, and also holds a Masters degree in Bioethics from the University of Sydney. Prior to joining CADTH, Renata has been involved in several multi-disciplinary research and policy initiatives examining the interface of ethics, health policy, and innovation
Lars Sandman, Director and Professor of healthcare ethics | National Centre for Priorities in Health at Linköping University
Lars Sandman is professor of healthcare ethics and director of the National Centre for Priorities in Health at Linköping university, Sweden. He is also an ethics consultant for the Swedish healthcare system and are part of different ethics councils and boards at different levels of the healthcare system. In this capacity, he is frequently commissioned to make ethics analyses as part of the decisional basis for healthcare decisions.